Drug sales in German pharmacies rose 7.1% in the first five months of 1996 to reach 10.2 billion Deutschemarks ($6.63 billion), reports the drug industry association, the BPI. The rise in western Germany was 6.6% and that in the eastern states was 9.2%.
Drug specialty prices in the reporting period went up 1.4%, with prices of pharmacy drugs up 2% and those of hospital drugs falling 1.4%. Volume accounted for 4.6% of the rise in sales, with price rises accounting for only 0.3% of growth.
The main reason for the increase during January-May was a wave of colds and flu, which started in 1995. Respiratory system drugs benefited in particular from this wave, increasing sales by 9.5%. Sales of anti-infectives increased 10.9% and central nervous system treatment sales were up 11.3%.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze